Publications by authors named "Helena D Aicher"

Claim this Profile
T
The Role and Ethics of Touch and Non-touch in Psychedelic-Assisted Therapy.
Helena D Aicher, Anke Röskamp, Marianne Moser, Manuela Brand

Curr Top Behav Neurosci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The translational potential of salvinorin A: systematic review and meta-analysis of preclinical studies.
Wolfgang Emanuel Zürrer, Lionel Wettstein, Helena D Aicher, Milan Scheidegger, Benjamin Victor Ineichen

Transl Psychiatry· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ayahuasca-inspired DMT/harmine formulation alters creative thinking dynamics during artistic creation.
Dila Suay, Helena D Aicher, Berit Singer, Michael J Mueller, Alen Jelusic

J Psychopharmacol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing psychedelic-assisted therapy: History and characteristics of the Swiss limited medical use program.
Matthias E Liechti, Peter Gasser, Helena D Aicher, Felix Mueller, Tadeusz Hawrot

Neurosci Appl· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ayahuasca-inspired DMT/HAR formulation reduces brain differentiation between self and other faces.
Dila Suay, Helena D Aicher, Micheal Kometer, Michael J Mueller, Luzia Caflisch

Neuroimage· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing mindfulness and compassion through an ayahuasca-inspired formulation containing N,N-DMT and harmine: A randomized controlled trial in healthy subjects.
Helena D Aicher, Ilhui A Wicki, Daniel Meling, Michael J Mueller, Dario A Dornbierer

J Psychopharmacol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: Α factorial dose-escalation study.
Klemens Egger, Javier Jareño Redondo, Jovin Müller, Joëlle Dornbierer, John Smallridge, Helena D Aicher

Biomed Pharmacother· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial.
Michael J Mueller, Helena D Aicher, Dario A Dornbierer, Laurenz Marten, Dila Suay

Int J Neuropsychopharmacol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychedelic therapy - refining the claim of a paradigm shift.
Helena D Aicher, Max Wolff, Uwe Herwig

Int Rev Psychiatry· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat.
Daniel Meling, Klemens Egger, Helena D Aicher, Javier Jareño Redondo, Jovin Mueller

J Psychopharmacol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors.
Klemens Egger, Helena D Aicher, Paul Cumming, Milan Scheidegger

Cell Mol Life Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects.
Helena D Aicher, Michael J Mueller, Dario A Dornbierer, Dila Suay, Claudius Elsner

Front Psychiatry· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-Dimethyltryptamine and harmine.
Dario A Dornbierer, Laurenz Marten, Jovin Mueller, Helena D Aicher, Michael J Mueller

Front Pharmacol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis